Pharmacy prescribing trial expands to include skin conditions
With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?
How pharmacists can support patients through the PrEP shortage
The Therapeutic Goods Administration has announced shortages on several brands of HIV PrEP medicines, concerning healthcare professionals.
Are GLP-1 RAs becoming lifelong medicines?
A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.
Pharmacy Future: Vision 2023
PSA has called for transformational change in the pharmacy profession within five years. So what could that future state look like?
‘By 2023, pharmacists within...
New list of banned drugs in sport released
The World Anti-Doping Agency (WADA) released an updated List of Prohibited Substances and Methods (the List).
The document, which is released annually, is part...
Tirzepatide users on oral contraceptives face pregnancy risk
New advice from the Therapeutic Guidelines highlights that tirzepatide could interfere with the efficacy of oral contraceptives.
